Diagnostic value of homogenous delayed enhancement in contrast-enhanced computed tomography images and endoscopic ultrasound-guided tissue acquisition for patients with focal autoimmune pancreatitis
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: We aimed to investigate (1) promising clinical findings for the recognition of focal type autoimmune pancreatitis (FAIP) and (2) the impact of endoscopic ultrasound (EUS)-guided tissue acquisition (EUS-TA) on the diagnosis of FAIP. Methods: Twenty-three patients with FAIP were involved in this study, and 44 patients with resected pancreatic ductal adenocarcinoma (PDAC) were included in the control group. Results: (1) Multivariate analysis revealed that homogeneous delayed enhancement on contrast-enhanced computed tomography was a significant factor indicative of FAIP compared to PDAC (90% vs. 7%, p=0.015). (2) For 13 of 17 FAIP patients (76.5%) who underwent EUS-TA, EUS-TA aided the diagnostic confirmation of AIPs, and only one patient (5.9%) was found to have AIP after surgery. On the other hand, of the six patients who did not undergo EUS-TA, three (50.0%) underwent surgery for pancreatic lesions. Conclusions: Homogeneous delayed enhancement on contrast-enhanced computed tomography was the most useful clinical factor for discriminating FAIPs from PDACs. EUS-TA is mandatory for diagnostic confirmation of FAIP lesions and can contribute to a reduction in the rate of unnecessary surgery for patients with FAIP.
Abstract
Background/Aims: We aimed to investigate (1) promising clinical findings for the recognition of focal type autoimmune pancreatitis (FAIP) and (2) the impact of endoscopic ultrasound (EUS)-guided tissue acquisition (EUS-TA) on the diagnosis of FAIP. Methods: Twenty-three patients with FAIP were involved in this study, and 44 patients with resected pancreatic ductal adenocarcinoma (PDAC) were included in the control group. Results: (1) Multivariate analysis revealed that homogeneous delayed enhancement on contrast-enhanced computed tomography was a significant factor indicative of FAIP compared to PDAC (90% vs. 7%, p=0.015). (2) For 13 of 17 FAIP patients (76.5%) who underwent EUS-TA, EUS-TA aided the diagnostic confirmation of AIPs, and only one patient (5.9%) was found to have AIP after surgery. On the other hand, of the six patients who did not undergo EUS-TA, three (50.0%) underwent surgery for pancreatic lesions. Conclusions: Homogeneous delayed enhancement on contrast-enhanced computed tomography was the most useful clinical factor for discriminating FAIPs from PDACs. EUS-TA is mandatory for diagnostic confirmation of FAIP lesions and can contribute to a reduction in the rate of unnecessary surgery for patients with FAIP.
참고문헌 (26)
- Kamisawa T, "A new clinicopathological entity of IgG4-related autoimmune disease", J Gastroenterol, 38, pp.982~984 (2003)
- Kamisawa T, "Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis", Gut, 52, pp.683~687 (2003)
- Okazaki K, "Clinical diagnostic criteria of autoimmune pancreatitis : revised proposal", J Gastroenterol, 41, pp.626~631 (2006)
- Kawaguchi K, "Lymphoplasmacytic sclerosing pancreatitis with cholangitis : a variant of primary sclerosing cholangitis extensively involving pancreas", Hum Pathol, 22, pp.387~395 (1991)
- Shimosegawa T, "International consensus diagnostic criteria for autoimmune pancreatitis : guidelines of the International Association of Pancreatology", Pancreas, 40, pp.352~358 (2011)
- Hart PA, "Long-term outcomes of autoimmune pancreatitis : a multicentre, international analysis", Gut, 62, pp.1771~1776 (2013)
- Chang MC, "Increase diagnostic accuracy in differentiating focal type autoimmune pancreatitis from pancreatic cancer with combined serum IgG4 and CA19-9 levels", Pancreatology, 14, pp.366~372 (2014)
- Pak LM, "The clinical utility of immunoglobulin G4 in the evaluation of autoimmune pancreatitis and pancreatic adenocarcinoma", HPB(Oxford), 20, pp.182~187 (2018)
- Furuhashi N, "Differentiation of focal-type autoimmune pancreatitis from pancreatic carcinoma : assessment by multiphase contrast-enhanced CT", Eur Radiol, 25, pp.1366~1374 (2015)
- He C, "A feasible CT feature to differentiate focal-type autoimmune pancreatitis from pancreatic ductal adenocarcinoma", Cancer Med, 8, pp.6250~6257 (2019)
- Zaheer A, "Differentiating autoimmune pancreatitis from pancreatic adenocarcinoma using dual-phase computed tomography", J Comput Assist Tomogr, 38, pp.146~152 (2014)
- Takahashi N, "Autoimmune pancreatitis : differentiation from pancreatic carcinoma and normal pancreas on the basis of enhancement characteristics at dual-phase CT", AJR Am J Roentgenol, 193, pp.479~484 (2009)
- Lee-Felker SA, "Use of MDCT to differentiate autoimmune pancreatitis from ductal adenocarcinoma and interstitial pancreatitis", AJR Am J Roentgenol, 205, pp.2~9 (2015)
- Sugumar A, "Endoscopic retrograde pancreatography criteria to diagnose autoimmune pancreatitis : an international multicentre study", Gut, 60, pp.666~670 (2011)
- Kanno A, "Diagnosis of autoimmune pancreatitis by EUS-guided FNA using a 22-gauge needle : a prospective multicenter study", Gastrointest Endosc, 84, pp.797~804 (2016)
- Morishima T, "Prospective multicenter study on the usefulness of EUS-guided FNA biopsy for the diagnosis of autoimmune pancreatitis", Gastrointest Endosc, 84, pp.241~248 (2016)
- Iwashita T, "Use of samples from endoscopic ultrasound-guided 19-gauge fine-needle aspiration in diagnosis of autoimmune pancreatitis", Clin Gastroenterol Hepatol, 10, pp.316~322 (2012)
- Kurita A, "Comparison of a 22-gauge Franseen-tip needle with a 20-gauge forward-bevel needle for the diagnosis of type 1 autoimmune pancreatitis : a prospective, randomized, controlled, multicenter study(COMPAS study)", Gastrointest Endosc, 91, pp.373~381 (2020)
- Ishikawa T, "Usefulness of endoscopic ultrasound-guided fine-needle biopsy for the diagnosis of autoimmune pancreatitis using a 22-gauge Franseen needle : a prospective multicenter study", Endoscopy, 52, pp.978~985 (2020)
- Koshita S, "Localized autoimmune pancreatitis, 9 mm in size, without strictures of the main pancreatic duct", Gastrointest Endosc, 75, pp.920~922 (2012)
- Cao Z, "Localized autoimmune pancreatitis: report of a case clinically mimicking pancreatic cancer and a literature review", Medicine(Baltimore), 94, pp.e1656~ (2015)
- Noda Y, "Diagnostic efficacy of the cell block method in comparison with smear cytology of tissue samples obtained by endoscopic ultrasound-guided fine-needle aspiration", J Gastroenterol, 45, pp.868~875 (2010)
- Sumimoto K, "A proposal of a diagnostic algorithm with validation of international consensus diagnostic criteria for autoimmune pancreatitis in a Japanese cohort", Pancreatology, 13, pp.230~237 (2013)
- Hewitt MJ, "EUS-guided FNA for diagnosis of solid pancreatic neoplasms : a meta-analysis", Gastrointest Endosc, 75, pp.319~331 (2012)
- Khan MA, "A meta-analysis of endoscopic ultrasound-fine-needle aspiration compared to endoscopic ultrasound-fine-needle biopsy : diagnostic yield and the value of onsite cytopathological assessment", Endosc Int Open, 5, pp.E363~ (2017)
- Chen G, "Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration for pancreatic cancer : a meta-analysis", Pancreatology, 13, pp.298~304 (2013)